Alnylam Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $20M | 73k | 275.03 |
| 2024-06-30 | $15M | 60k | 243.00 |
| 2024-03-31 | $2.3M | 15k | 149.45 |
| 2023-03-31 | $2.6M | 13k | 200.32 |
| 2022-12-31 | $295k | 1.2k | 237.65 |
| 2021-06-30 | $1.5M | 9.0k | 169.57 |
| 2021-03-31 | $2.1M | 15k | 141.21 |
| 2020-12-31 | $1.3M | 10k | 129.95 |
| 2019-12-31 | $213k | 1.9k | 115.14 |
| 2014-12-31 | $495k | 5.1k | 97.06 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management